Clinicaltrials.gov identifier:
NCT04995198 (https://clinicaltrials.gov/show/NCT04995198)
Surveys, Registries, Interviews
Study Contact Information:
Contact the study coordinator at this email:
Study phone line: 646-449-3363
PROMISE is a nationwide registry of prostate cancer patients with inherited mutations by screening approximately 5,000 participants with a prostate cancer diagnosis.
The PROMISE team is studying how these mutations affect patient outcomes. We hope to help patients learn more about their disease, the treatments that they may benefit most from, and any research studies that they may be eligible for.
Visit prostatecancerpromise.org to learn more about the study and sign up.
Study participants will be asked to:
PROMISE is completely free. Participants don’t have to leave their current healthcare provider or their house to join.
Co-PI: Heather Cheng, MD PhD
Fred Hutchinson Cancer Research Center
University of Washington
Co-PI: Channing Paller, MD
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University
Study Sponsor and Coordinating Center: Prostate Cancer Clinical Trials Consortium
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.